A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation

• Main Authors: Min Jiang (Author), Lixian Liu (Author), Ruiwu Liu (Author), Kit S. Lam (Author), Nancy E. Lane (Author), Wei Yao (Author)
• Formato: Livro
• Publicado em: BMC, 2020-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Currently, there are no effective medications to reverse periodontal disease (PD)-induced bone loss. The objective of this study was to test a new anabolic compound, LLP2A-Ale, or with the combination treatment of mesenchymal stromal cell (MSC), in the treatment of bone loss seco...